Loss of chromosome Y shortens lifespan and increases cardiomyopathy in a male mouse model. Human cohorts link it with higher cardiovascular and lung disease risk. However, a study of men after acute myocardial infarction links greater loss with fewer subsequent major cardiovascular events, and a preprint reports no clear association with frailty.
103 findings in 51 papers from 2013 to 2026, 18 of them since May 2026
“Among five well-represented neural cell types, LOY was enriched in microglia and rare in neurons, astrocytes, and oligodendrocytes.”
Loss of chromosome Y is linked with lower white blood cell count in AML/MDS with high LOY burden (≥ 75%) (p < 0.05).
“A high LOY burden (≥ 75%) was associated with cytopenias in AML/MDS, characterized by decreased white blood cell (WBC) count, neutrophil count (NEC), and platelet (PLT) count (p < 0.05).”
Humansin AML/MDS with high LOY burden (≥ 75%)bloodmales
Loss of chromosome Y is associated with cancer in humans.
“mLOY is associated with a wide variety of pathologies in men, such as cardiovascular diseases, neurodegenerative disorders, and many types of cancer.”
Loss of chromosome Y raises the risk of cancer in humans (hematopoietic).
“Hematopoietic mosaic loss of Y chromosome (mLOY) has emerged as a potential male-specific accelerator of biological aging, increasing the risk of various age-related diseases, including cancer.”
Loss of chromosome Y raises the risk of cancer in humans.
“harboring cells without the Y chromosome in the peripheral blood is associated with increased risk for all-cause mortality and disease such as different forms of cancer”
Loss of chromosome Y raises the risk of Alzheimer's disease in humans.
“harboring cells without the Y chromosome in the peripheral blood is associated with increased risk for all-cause mortality and disease such as different forms of cancer, Alzheimer's disease”
Loss of chromosome Y is associated with peripheral artery disease in humans (37% higher risk; 95% CI 1.18–1.60; P < 0.001).
“the presence of mLOY was associated with 72% higher risk of PAD in Model 1 (95% CI: 1.48-2.00) and a 37% higher risk in Model 2”
HumansWithout PAD at baseline; Model 2 adjusted for age, ancestry, socioeconomic, lifestyle, clinical, and genetic factorsMedian follow-up of 15.2 yearsmalesn = 185,429
Loss of chromosome Y is associated with major adverse cardiovascular events in humans (Recent acute myocardial infarction; multivariable-adjusted analysis) (aHR 0.95 (0.90-0.99) per % increase, p=0.048).
“the risk of MACE decreased with increasing LOY (aHR 0.95 (0.90-0.99) per % increase, p=0.048)”
Loss of chromosome Y raises the risk of lung cancer in aging men.
“mLOY markedly increases the incidence, progression, and adverse prognosis of multiple diseases, including, but not limited to, myocardial fibrosis, lung and bladder cancers”
Loss of chromosome Y is associated with cardiovascular disease in humans.
“population-based genome-wide association study (GWAS) analyses have identified robust epidemiological associations between hematopoietic LOY and cardiovascular disease”
Loss of chromosome Y is associated with cardiovascular disease in humans.
“mLOY is associated with a wide variety of pathologies in men, such as cardiovascular diseases, neurodegenerative disorders, and many types of cancer.”
Loss of chromosome Y shortens lifespan and increases cardiomyopathy in a male mouse model; human cohorts link it with mortality and cardiovascular and lung disease. Cardiovascular associations differ: a study of men after acute myocardial infarction links greater loss with fewer subsequent adverse cardiovascular events. A preprint finds no clear link with frailty in humans.
Loss of chromosome Y shortens lifespan and increases cardiomyopathy in a male mouse model; human studies link it with mortality and cardiovascular disease. These associations vary by population: a study in men after acute myocardial infarction links greater loss with fewer major cardiovascular events, while a preprint finds no clear link with frailty.
Summary rewritten as its findings changed.
As it read before
Loss of chromosome Y shortens lifespan and increases cardiomyopathy in a male mouse model, while human cohorts link it with mortality and cardiovascular disease. Associations differ by population: men after a recent myocardial infarction show a link with fewer subsequent major cardiovascular events, and men with clonal hematopoiesis show no clear link with myocardial infarction.
Summary rewritten as its findings changed.
As it read before
One human study finds loss of chromosome Y has no effect on frailty. Reviews link it to male lifespan, myocardial fibrosis, Alzheimer's disease, and lung cancer in aging men, as well as increased cardiac fibrosis in male mice.
Men with Y chromosome loss in blood cells had a 37% higher relative risk than men without it, after adjustment for other factors.Men with Y chromosome loss in blood cells had a 37% higher relative risk than men without it, after adjustment for other factors.
Among 176,468 men followed for a median 15.25 years, Y chromosome loss in blood cells was linked to abdominal aneurysms that caused symptoms.Among 176,468 men followed for a median 15.25 years, Y chromosome loss in blood cells was linked to abdominal aneurysms that caused symptoms.
Who was studied176,468 men free of AAA at baseline, median 15.25 years
What changedIncident symptomatic abdominal aortic aneurysm risk was higher with each standard deviation increase in chromosome Y loss (adjusted HR 1.01-1.09)
The catchThe cohort was predominantly of European ancestry
Hazard ratios, measuring relative disease rates, were 1.08 for non-sex-chromosome changes and 1.04 for Y-chromosome loss, compared with people without the respective…Hazard ratios, measuring relative disease rates, were 1.08 for non-sex-chromosome changes and 1.04 for Y-chromosome loss, compared with people without the respective change.
Who was studied419,762 UK Biobank participants, against people without the respective change
What changedCardiovascular disease incidence was higher: hazard ratios were 1.08 for non-sex-chromosome changes and 1.04 for Y-chromosome loss against people without them
The catchThe study excluded people with existing cardiovascular disease or blood cancer
An observational study of 223,051 UK Biobank men linked Y-chromosome loss in blood cells to later age-related macular degeneration.An observational study of 223,051 UK Biobank men linked Y-chromosome loss in blood cells to later age-related macular degeneration.
Analyses of human kidney tumors, mice and cell lines showed that losing the Y chromosome produces few broad changes in gene activity across cancers.Analyses of human kidney tumors, mice and cell lines showed that losing the Y chromosome produces few broad changes in gene activity across cancers.
A large genomic analysis reveals over 800 inherited variants and structural features that alter how frequently chromosomes missegregate in aging individuals.A large genomic analysis reveals over 800 inherited variants and structural features that alter how frequently chromosomes missegregate in aging individuals.
Preprint: cohort study of 840,853 peopleMechanisms
An analysis of 730,088 participants across four cohorts found clonal hematopoiesis was strongly associated with incident frailty and faster functional decline.An analysis of 730,088 participants across four cohorts found clonal hematopoiesis was strongly associated with incident frailty and faster functional decline.